Laparoscopic sleeve gastrectomy: a review of the clinical benefits and harms
Canadian Agency for Drugs and Technologies in Health
Record ID 32011001192
English
Authors' recommendations:
It has been suggested that LSG may have advantages over other bariatric surgeries. Evidence from one RCT with an uncertain risk of bias suggested that LSG is associated with greater weight loss than LAGB after three years of follow-up and may have a lower incidence of complications. In two RCTs and one controlled clinical trial, weight loss with LSG appeared to be similar to LRYGB, with possible fewer nutrient deficiencies noted in one study. However, the study in which nutrient deficiencies were assessed had some methodological limitations which could compromise the validity of its findings. Guidelines for bariatric surgery support the use of LSG for weight loss; however, no guidance is offered as to when this technique would be preferable over others. At present, there is limited evidence of uncertain quality upon which to base policy decisions about the use of LSG in the management of obesity. With these limitations in mind, LSG does appear to be equally or more effective as other bariatric surgeries.
Details
Project Status:
Completed
Year Published:
2010
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Laparoscopy
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.